October 12, 2023- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy, announced the launch of its new Introcan Safety® 2 IV Catheter with Multi-Access Blood Control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun in a long line of passive needlestick prevention catheters. In addition to automatic needlestick protection, clinicians are protected from blood exposure by a blood control feature every time the hub is accessed, reducing the risk of bloodborne pathogen exposure throughout the IV process.
IV access is a critical element of infusion therapy, and needlestick injuries continue to be a serious risk faced by clinicians in their daily routines, potentially exposing them to bloodborne pathogens. Studies show that passive, fully automatic safety devices prevent needlestick injuries two times better than a semi-automatic “push button” safety shield and three times better than a manually sliding shield.With the Introcan Safety 2 Catheter, clinicians are protected by a truly automatic passive safety device.
In addition to needlestick injuries, mucocutaneous blood exposure due to blood spillage from the catheter hub is also a concern. Blood control IV catheters have been shown to significantly reduce the risk of blood exposure and the workload associated with cleaning.In addition, results of a survey point to a potential reduction of costs associated with blood cleanup time and materials.